SpringWorks Therapeutics logo

SpringWorks Therapeutics

BrandStamford, ConnecticutWebsite

Company Overview

SpringWorks Therapeutics, a healthcare company of Merck KGaA, Darmstadt, Germany, is a commercial-stage biopharmaceutical company dedicated to improving the lives of patients with rare tumors. We developed and are commercializing the first and only FDA and EC approved medicine for adults with desmoid tumors and the first and only FDA and EC approved medicine for both adults and children with neurofibromatosis type 1 associated plexiform neurofibromas (NF1-PN). At SpringWorks, we are committed to finding answers people with rare tumors need. We thrive in an atmosphere of passion and tenacity, fueled by the excitement of the possibilities science may unlock and driven to work with urgency because of the importance of our work. We value authenticity because diverse backgrounds, cultures, styles and abilities can only help us find the answers that people with rare tumors are looking for.
Founded
2017
Headquarters
Stamford, Connecticut
Employees
201-500
9.6% growth last 12mo
Marketing Team
27
6% of company

Overall Headcount Trend

Overall Headcount Trend

Company growth over the last 12 months

Salaries

Job Posting Salary Data

From 1 marketing roles posted in the last 12 months

Typical Salary Range
$165,000$230,000
YEAR
100%
share salary

Community Salary Data

Help build salary transparency at SpringWorks Therapeutics. Share your compensation anonymously.

Contribute

Reviews

Jobs